J F Davies - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J F Davies

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Proceedings of the National Academy of Sciences of the United States of America|April 11, 1995

Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus proteaseS H Reich, M Melnick, J F Davies, et al.

Journal of Medicinal Chemistry|July 5, 1996

Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative designM Melnick, S H Reich, K K Lewis, et al.

Journal of Medicinal Chemistry|December 16, 1997

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Proceedings of the National Academy of Sciences of the United States of America|April 11, 1995

Protein structure-based design of potent orally bioavailable, nonpeptide inhibitors of human immunodeficiency virus proteaseS H Reich, M Melnick, J F Davies, et al.

Journal of Medicinal Chemistry|July 5, 1996

Bis tertiary amide inhibitors of the HIV-1 protease generated via protein structure-based iterative designM Melnick, S H Reich, K K Lewis, et al.

Journal of Medicinal Chemistry|December 16, 1997

Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.

Pageof 2